Table of Contents

doi : 10.1016/S0923-7534(25)06294-5

خرید پکیج و مشاهده آنلاین مقاله

Editorial Board

doi : 10.1016/S0923-7534(25)06295-7

Volume 37, Issue 1, January 2026, Pages i-ii

خرید پکیج و مشاهده آنلاین مقاله

Thanks to Referees 2025

doi : 10.1016/j.annonc.2025.11.001

خرید پکیج و مشاهده آنلاین مقاله

Positioning EGFR re-treatment in modern metastatic colorectal cancer: insights from PARERE

doi : 10.1016/j.annonc.2025.10.008

خرید پکیج و مشاهده آنلاین مقاله

Long-term survival in the ALEX trial: a milestone in improving the prognosis of patients with ALK-positive non-small-cell lung cancer

doi : 10.1016/j.annonc.2025.10.001

خرید پکیج و مشاهده آنلاین مقاله

Improved survival and rising incidence: insights from the largest retrospective study on leptomeningeal metastases in patients with NSCLC: Editorial on: The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

doi : 10.1016/j.annonc.2025.10.014

خرید پکیج و مشاهده آنلاین مقاله

Combination with BCG induction and maintenance therapy for high-risk non-muscle invasive bladder cancer

doi : 10.1016/j.annonc.2025.10.015

خرید پکیج و مشاهده آنلاین مقاله

Nivolumab and cabozantinib combination therapy demonstrates sustained efficacy in metastatic renal-cell carcinoma

doi : 10.1016/j.annonc.2025.10.1238

خرید پکیج و مشاهده آنلاین مقاله

ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors

doi : 10.1016/j.annonc.2025.09.008

خرید پکیج و مشاهده آنلاین مقاله

Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial☆

doi : 10.1016/j.annonc.2025.09.006

خرید پکیج و مشاهده آنلاین مقاله

ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC)☆

doi : 10.1016/j.annonc.2025.09.017

خرید پکیج و مشاهده آنلاین مقاله

Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study☆

doi : 10.1016/j.annonc.2025.10.004

خرید پکیج و مشاهده آنلاین مقاله

Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274☆

doi : 10.1016/j.annonc.2025.09.139

خرید پکیج و مشاهده آنلاین مقاله

Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO☆

doi : 10.1016/j.annonc.2025.10.002

خرید پکیج و مشاهده آنلاین مقاله

Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study☆

doi : 10.1016/j.annonc.2025.09.018

خرید پکیج و مشاهده آنلاین مقاله

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study☆

doi : 10.1016/j.annonc.2025.09.140

خرید پکیج و مشاهده آنلاین مقاله

TRADE: a phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR-positive/HER2-negative breast cancer☆

doi : 10.1016/j.annonc.2025.09.141

خرید پکیج و مشاهده آنلاین مقاله

Rethinking survival metrics in EGFR-mutated NSCLC: insights from RMST analysis of FLAURA2 and MARIPOSA

doi : 10.1016/j.annonc.2025.10.1235

خرید پکیج و مشاهده آنلاین مقاله